Using next-generation sequencing technology to identify genetic determinants of epilepsy and sporadic epilepsy prognosis

在高通量、下一代DNA测序方面的最新进展使生物学家能够同时分析受影响和未受影响的个体之间数千个不同基因的差异。然而，它产生了压倒性的数据量，理解这种数据洪流是当前的挑战。克服这一挑战将使疾病致病变种的科学发现成为可能，有可能为有针对性的药物开发提供机会。

Recent advances in high-throughput, next-generation, DNA sequencing allows biologists to simultaneously analyse the differences in thousands of different genes across affected and unaffected individuals. However, it produces an overwhelming amount of data and making sense of this deluge of data is a current challenge. Overcoming this challenge will enable scientific discoveries of pathogenic variants of disease, potentially providing an opportunity for targeted drug development.